Report Overview:
Lactulose syrup is a liquid formulation of lactulose, a synthetic sugar primarily used as a laxative for treating constipation. It also serves as a prebiotic, promoting the growth of beneficial bacteria in the colon. The syrup works by drawing water into the bowel, softening stools and facilitating bowel movements. Additionally, it is used in the management of hepatic encephalopathy by reducing ammonia levels in patients with liver disease.
Market Value:
The global lactulose syrup market was valued at approximately USD 125 million in 2024 and is projected to reach USD 157.48 million by 2032, growing at a CAGR of 2.60% during the forecast period.
By Types:
• Chemical Synthesis
• Enzymatic Method
By Applications: Pharmaceuticals
Key players include:
• Abbott
• Morinaga
• Fresenius Kabi
• Illovo
• Biofac
• Dandong Kangfu
• Including or Excluding key companies relevant to your analysis.
